Switch to:
Cascadian Therapeutics Inc  (NAS:CASC) EBITDA: $-47.29 Mil (TTM As of Jun. 2017)

Cascadian Therapeutics Inc's EBITDA for the three months ended in Jun. 2017 was $-14.84 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was $-47.29 Mil.

During the past 3 years, the average EBITDA Growth Rate was 16.40% per year. During the past 5 years, the average EBITDA Growth Rate was 32.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Cascadian Therapeutics Inc was 131.70% per year. The lowest was -46.40% per year. And the median was 9.80% per year.

Cascadian Therapeutics Inc's EBITDA per Share for the three months ended in Jun. 2017 was $-0.30. Its EBITDA per share for the trailing twelve months (TTM) ended in Jun. 2017 was $-1.51.

During the past 3 years, the average EBITDA per Share Growth Rate was -5.20% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Cascadian Therapeutics Inc was 91.80% per year. The lowest was -60.20% per year. And the median was -9.50% per year.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Cascadian Therapeutics Inc Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.59 -40.73 -50.32 -32.18 -64.19

Cascadian Therapeutics Inc Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.32 -10.64 -10.43 -11.38 -14.84

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cascadian Therapeutics Inc's EBITDA for the fiscal year that ended in Dec. 2016 is calculated as

Cascadian Therapeutics Inc's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2016, Cascadian Therapeutics Inc's EBITDA was $-64.19 Mil.

Cascadian Therapeutics Inc's EBITDA for the quarter that ended in Jun. 2017 is calculated as

Cascadian Therapeutics Inc's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Jun. 2017, Cascadian Therapeutics Inc's EBITDA was $-14.84 Mil.

EBITDA for the trailing twelve months (TTM) ended in Jun. 2017 was -10.635 (Sep. 2016 ) + -10.431 (Dec. 2016 ) + -11.383 (Mar. 2017 ) + -14.838 (Jun. 2017 ) = $-47.29 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EDITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also price/EBITDA is sometimes used in valuations.


Related Terms


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK